The rating affirmation is based on a number of factors, including Holy Redeemer’s low revenue growth and challenges operating in a competitive Philadelphia market with concentrated payers.
The outlook is stable, reflecting expected maintenance of balance sheet strength to mitigate risks of volume declines in a competitive market.
More articles on healthcare finance:
How CHS, Tenet, UHS, LifePoint and HCA fared in Q4
Artificial Medical Intelligence introduces new coding and reimbursement software: 5 things to know
AG to Minn. hospitals: Refund sexual violence victims
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
